Ajanta Pharma posts Q4 FY24 consolidated PAT at Rs. 202.72 Cr
The company has reported total income of Rs. 1,089.58 crores during the period ended March 31, 2024
The company has reported total income of Rs. 1,089.58 crores during the period ended March 31, 2024
Ajanta Pharma has reported total income of Rs. 1049.77 crores during the period ended September 30, 2023
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
The company has reported total income of Rs. 1052.79 crores during the period ended June 30, 2023
The company has reported total income of Rs. 918.67 crores during the period ended March 31, 2023
Subscribe To Our Newsletter & Stay Updated